New research suggests that individuals who come off popular GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop conventional lifestyle plans.
Findings released in a major medical journal demonstrates that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People using these treatments must be aware of the potential of rapid weight regain when the medication is stopped," stated expert Dr. Susan Jebb.
Such speed of regain means a reversion to starting weight within about a year and a half.
Comparing Treatments
The analysis, which examined dozens of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists point out that individuals who lose weight through dieting typically experience a less rapid weight regain—around 100 grams monthly—once they finish.
Understanding the Quick Rebound
Nutrition scientists believe the mode of action of the injections accounts for the heightened regain.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of GLP-1 levels far above than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication means hunger is unsuppressed, making overeating far more likely."
An Ongoing Disease?
Medical guidelines advise the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians contend that, given the likelihood of relapse, the treatment might need to be ongoing.
This view is supported by pharmaceutical companies, who note that the findings "emphasize the chronic nature of excess weight," comparing it to managing conditions like diabetes.
User Experiences
Users who have come off the jabs report a intense return of cravings.
"It felt as if something flipping and you're instantly ravenous," recalled an individual.
This difficulty is worsened if individuals have not developed sustainable dietary or behavioural modifications during therapy.
Growing Adoption
Figures show that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is higher among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Finally, experts emphasize that while these medications are effective tools for shedding pounds, they are not a standalone solution and long-term success relies on combined lifestyle support.